Month: 2025-04

TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation ("Hitachi High-Tech") has revised its corporate vision and mission effectivetoday.Corporate VisionChanging the World and Future with the Power of KnowledgeMissionWe provide solutions that will realize a sustainable society tomorrow through a deeper understanding of the issues facing society and ourcustomers todayWhile digitalization and development of AI and other technologies are rapidly accelerating, the future of thesocial environment surrounding us is uncertain due to increasing complexity and volatility caused by naturaldisasters, climate change, geopolitical risks and so on. Given this context, Hitachi High-Tech Group believesthat the crucial first step in changing the world and shaping the future is to deeply understand the rootcauses occurring around society and our customers, so that we can identify the hidden problems that areunrecognized by our customers and partners.Hitachi High-Tech has cultivated a variety of “Power of Knowledge” over the years, including Observation, Measurement, and Analysis technologies, global network, world-class products, and co-creative relationships with our customers and partners. By leveraging our "Power of Knowledge," eachemployee of Hitachi High-Tech Group will continue to provide solutions for the issues facing society andour customers today to realize a sustainable society tomorrow.About Hitachi High-Tech’s Corporate Vision and MissionSee here for more details. Corporate Vision: Hitachi High-Tech Corporation Copyright 2025 JCN Newswire via SeaPRwire.com.

Strengthening Our Analytical Business to Solve Social Issues with Our Core TechnologiesTOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation ("Hitachi High-Tech") is strengthening its analytical businessthrough integrating and jointly operating its Hitachi High-Tech Analytical Science Ltd. ("Hitachi High-Tech Analytical Science") and Hitachi High-Tech Science Corporation ("Hitachi High-Tech Science") businesses.As of April 1, 2025, Hitachi High-Tech Science will become Hitachi High-Tech Analysis Corporation as part of this re-structure.By integrating the core technologies of both companies, we will be better equipped to address the increasingly complex processes involved in developing, manufacturing, and inspecting materials that our customers encounter. Bringing together X-ray fluorescence (XRF), optical emission spectroscopy (OES), laser induced breakdown spectroscopy (LIBS), thermal analysis (TA), liquid chromatography and spectrophotometers from Hitachi High-Tech Analytical Science and Hitachi High-Tech Science will facilitate the development of new, innovative solutions.Initiatives to create a safe and secure society, and reducing environmental impact are becoming increasingly important across a wide range of business fields including healthcare, semiconductors and electronic components, and batteries. The analytical division and beam technology division, which includes electron microscopes, are key to supportingHitachi High- Tech Group's Core Technology Solutions business. The Core Technology Solutions division leverages its expertise in Observation, Measurement, and Analysis to offer specialized solutions for measurement and inspection. These solutions support the R&D, manufacturing, and quality control processes, helping to address both customer and societal challenges.Whilst manufacturing processes are becoming more complex, waste reduction, circular economy and preservation of raw materials are key to a more sustainable, global industry.Hitachi High-Tech Group will use the “Power of Knowledge” it possesses to know accurately and leveraging deepunderstandings the genuine issues of society and customers, and we will contribute to create a sustainable society by solving these issues.About Hitachi High-Tech ScienceHitachi High-Tech Science supports a wide range of R&D and quality control operations through the development, manufacture, sale and maintenance of various analytical instruments for physical property analysis (thermal analysis,spectroscopy), elemental analysis (X-ray fluorescence, ICP, atomic absorption) and organic analysis (liquid chromatographs), along with the sale of related parts and consumables.About Hitachi High-Tech Analytical ScienceHitachi High-Tech Analytical Science, with locations in the UK, Germany, Finland and China, specializes in a widerange of connect materials analysis products and services for use in the lab or in-field. Our advanced, cutting-edge XRF,LIBS and OES solutions enable fast, accurate decisions during the production process whether they relate to raw material sourcing, quality control, end of life disposal or recycling.Contact:Osamu MatsuzawaBusiness Planning Department, Business Management Division Hitachi High-Tech Science CorporationE-mail: osamu.matsuzawa.wp@hitachi-hightech.com Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi High-Tech Corporation announced that the new production facility for semiconductormanufacturing equipment (etch systems), which had been under construction since December 2023 in the Kasado area (Kudamatsu City, Yamaguchi Prefecture), was completed and started the operation on March 17, 2025.We aim to increase production capacity through digitalized and automated production lines in the new productionfacility. In addition, a comfortable work environment has been created with employee well-being taken into account, while achieving carbon neutrality through the use of renewable energy.Semiconductor-related markets are expected to continue to grow and expand due to increasing demand for generativeAI and autonomous driving in the future. With the start of the new production facility's operation, we will continue tocreate new value and solve customers’ issues by shortening development periods, reducing costs, and improving productivity.Hitachi High-Tech will continue to pursue and create new value together with our customers in order to contribute to sustainable industrial development that supports cutting-edge manufacturing and digital society, and to the realization of a sustainable society by solving social issues.About Hitachi High-TechHitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, radiation therapy systems, semiconductor manufacturing equipment, analytical instruments, and analysis equipment. Also, we provide high value-added solutions in industrial fields such as mobility, connected, environment and energy, etc. Through business based on our core Observation, Measurement and Analysis technologies, we will contribute to the realization of a sustainable society by solving social issues.The company's consolidated revenues for FY2023 were approx. JPY 670.4 billion. For further information, visit https://www.hitachi-hightech.com/global/en/Contact:Kasado General Affairs Dept.,Human Resources & General Affairs Div., Hitachi High-Tech CorporationTel: +81-833-41-8704 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and successfully demonstrated a technology that enables face recognition without storing patients' facial information and ensures traceability through the entire workflow process for personalized cancer vaccine. Moreover, NEC has developed and successfully demonstrated a new technology that requires minimal validation data to effectively manage sensitive information.This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies (1).Personalized cancer vaccines are developed by analyzing genomic data on a patient's tissue and blood samples, making accurate administration crucial since each vaccine is tailored to the individual. The workflow for these vaccines is more complex than that of conventional vaccines and is expected to expand as the number of patients increases. Therefore, integrating ICT into the workflow is essential to enhance safety and efficiency, facilitating the realization and widespread adoption of personalized cancer vaccine therapies.In addition to advancing personalized cancer vaccines through AI, NEC has also developed technologies to enhance vaccine manufacturing management. Furthermore, NEC has been actively involved in comprehensive ICT-based activities to produce personalized cancer vaccine therapies, including the publication of a white paper (2).NEC has now developed and demonstrated the following technologies for in-house PoCs.Workflow for Personalized Cancer Vaccines1. Biometric based digital signature that enables face recognition and ensures traceability without storing facial information (3)Since personalized cancer vaccines are developed based on patients' genomic data, they must be administered to the correct patient without any mix-ups, requiring highly reliable identification. In addition to verifying patients’ names and IDs, biometric recognition can further enhance identification reliability when collecting samples or administering vaccines. However, the use of biometric recognition requires the secure management of biometric information.NEC has developed a proprietary digital signature technology that enables face recognition without storing facial information. This is accomplished by converting the feature information of facial images into key information. This technology enables authentication using key information, enhancing the reliability of vaccine administration without the risk of misuse or leakage of sensitive facial information. In addition, the digital signature generated by this technology can be used to verify and trace the correct patient identification at the time of vaccine administration, without using facial information.Identification utilizing a biometric based digital signature2. Tampering detection technology that reduces the amount of validation data required to securely store sensitive informationSince personalized cancer vaccines are developed based on a patient's genomic data, ensuring the authenticity of the data is important. One solution is to use a tampering detection technology that attaches validation tag data to verify the genomic data. However, a large amount of genomic data and an enormous amount of tag data are required when large amounts of patient data need to be managed. Therefore, conventional tampering detection technologies face difficulties with tag data verification time and storage cost.NEC has developed a tampering detection technology that reduces the amount of validation tag data by grouping genomic data and assigning validation tags accordingly. This technology reduces the amount of tag data by 90% while maintaining the same level of tamper detection accuracy as the conventional methods of assigning tag data to each genomic data. Consequently, it lowers the storage cost of tag data while ensuring the authenticity of patient genomic data.Tampering detection for the genomic and vaccine data with minimal validation dataTo verify the capabilities of these technologies, NEC built an environment that simulates the actual workflow for personalized cancer vaccines. In tests that simulated mix-ups of patients or samples, it was confirmed that the biometric based digital signature technology can correctly detect a mix-up before a vaccine is administered, and that the tampering detection technology can detect if genomic data has been tampered with.Looking ahead, NEC will continue to approach the production of personalized cancer vaccine therapies from various perspectives, including further research and development based on these results.(1) According to an NEC survey as of April 1, 2025(2) NEC white paper proposes a comprehensive process workflow for the application of AI-driven personalized cancer vaccines: www.nec.com/en/press/202404/global_20240408_01.html(3) NEC develops biometric based digital signature technology that enables face recognition without storing facial information: www.nec.com/en/press/202502/global_20250226_03.html About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the launch of Miland, a virtual car lifestyle app that connects users and their friends, in the Japanese market(1) today. The app was developed in collaboration with JP UNIVERSE Inc.(2)In its mid-term business plan "Challenge 2025," Mitsubishi Motors has set creating seamless and efficient touchpoints with customers through digital transformation (DX) as a key strategy. The plan particularly focuses on Generation Z, who are digital natives and will become the core automotive purchasing and user group in 10 years, as well as business transformation and the creation of new businesses using digital technologies. To achieve this, open innovation, or co-creation, is positioned as a key measure, involving the development of new services through collaboration with a diverse range of people and technologies both inside and outside the company.The name of the service, Miland, is derived from the phrase “unexplored lands created by Mitsubishi Motors,” and was coined in the hope that people would discover new ways to enjoy cars in unexplored territories. It enables young people, particularly Generation Z, who do not own cars to experience the joy of having a car. In the virtual world, users can enjoy owning cars, driving with friends, and customizing their vehicles. Developed in collaboration with JP UNIVERSE, a group of creators specializing in immersive space services, the app offers a highly immersive and enjoyable experience.FeaturesEasily own cars in the virtual world- Users can own digital cars and garages, allowing for a simulated experience of car ownership. If converted to a Non-Fungible Token (NFT), the car becomes a personal asset, and can be bought and sold on the NFT marketplace(3) OpenSea, operated by Ozone Networks, Inc.Experience driving interactions with friends similar to social networking- Even when in different locations, users can communicate with friends as if they are driving together in the same space or vehicle. With map designs that offer unique virtual environments, users can drive along distinctive courses. It is also possible for users to drive together with a common mission.Customize cars in various ways- Cars can be customized by changing their color or adding stickers. Users can also personalize their cars with limited-time or mission-exclusive stickers. In addition, events and other special activities are planned for the future.Service introduction page (in Japanese only): https://relight-lab.mitsubishi-motors.com/milandtopTo expand the value of automobiles in line with the changing values of users brought about by digitization, Mitsubishi Motors has also launched the "Relight Lab" open innovation site today. This site will serve as a platform to implement new digital services, and seeks top runners in emerging technologies in the digital world as well as those skilled at building new digital services. By combining technology and ambition, the aim is to achieve open innovation, leading to the creation of new services from Mitsubishi Motors.Website (in Japanese only): https://relight-lab.mitsubishi-motors.com(1) The app is offered in Japanese and is available only in the Japanese market.(2) JP UNIVERSE Inc. (Representative: Hajime Tabata, CEO) was established on February 8, 2022. The company provides gamification platforms, game commerce, platform provision and operation, and XR production.(3) Available from early AprilAbout Mitsubishi MotorsMitsubishi Motors Corporation (TSE:7211) — a member of the Alliance with Renault and Nissan — is a global automobile company based in Tokyo, Japan, which has about 28,000 employees and a global footprint with production facilities in Japan and the ASEAN region. Mitsubishi Motors has a competitive edge in SUVs, pickup trucks and plug-in hybrid electric vehicles, and appeals to ambitious drivers willing to challenge convention and embrace innovation. Since the production of our first vehicle more than a century ago, Mitsubishi Motors has been a leader in electrification — launched the i-MiEV, the world’s first mass-produced electric vehicle in 2009, followed by the Outlander PHEV, the world’s first plug-in hybrid electric SUV in 2013. With a target of increasing the sales ratio of electrified vehicles to 100% by 2035, Mitsubishi Motors will deliver models that embody Mitsubishi Motors-ness and contribute to the realization of a carbon-neutral society.For more information on Mitsubishi Motors, please visit the company's website at www.mitsubishi-motors.com/en/ Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Apr 1, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation (MC), Mitsubishi Corporation Urban Development Co., Ltd. (MCUD), and iPark Institute Co., Ltd. (iPi) are pleased to announce our joint development of a new, rental-lab-type R&D facility in Kobe Biomedical Innovation Cluster (KBIC). The facility, which has been tentatively named "iPark Kobe," will augment progress being made in KBIC to establish a community based on institutions dedicated to research and development. MCUD signed an agreement today with Kobe's municipal authorities to purchase land for the facility's construction on Kobe Port Island, which is owned by Kobe City.Growth in semiconductors, medical treatment and other cutting-edge industries has accelerated in recent years, which has given rise to the formation of unique industrial zones due to the large number of R&D interests and related businesses. As a consequence, facilities engaged in research and development are rapidly becoming the epicenters of new communities.Kobe City began developing KBIC in 1998 to promote an accumulation of medical care-related entities, including R&D facilities, hospitals and private enterprises. Now boasting more than 350 resident organizations, KBIC has grown into one of the largest medical care industrial clusters in Japan, making it a leading example of MC's mission to position advanced industries at the core of its urban development work.The land-purchase agreement was reached due to KBIC being the ideal location for the first "iPark" drug-discovery and bioresearch facility to be established outside Japan's Shonan region. MC, MCUD and iPi all have strong track records when it comes to advanced-industry facilities.MCUD has a wealth of expertise in developing high-performance distribution warehouses and shared manufacturing and R&D centers, while iPi has demonstrated its management capabilities in operating the Shonan iPark science park.Our three companies look forward to combining our respective know-how and networks to develop and manage iPark Kobe in ways that will help Kobe City achieve its community-building mission in KBIC. We are committed to exploring ideas that can drive further innovation and lead to more large-scale urban development projects that are built around R&D facilities.Outline of the Project SiteThe site is located in Kobe Medical Industry City, the second phase of Kobe Port Island, and will be directly connected to Kobe New Transit Port Liner Keisan Kagaku Center Station by a connecting deck. It is accessible in about 16 minutes from Sannomiya Station, which is the city's largest shopping district and transportation node, and in about 6 minutes from Kobe Airport Station.Inquiry RecipientMitsubishi CorporationTelephone: +81-3-3210-2171 Copyright 2025 JCN Newswire via SeaPRwire.com.